NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

AMPLIA THERAPEUTICS LIMITED (ATX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of ATX: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare Melbourne
Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000023822
Address: Level 17, 350 Queen St, Melbourne VIC 3000 AUSTRALIA
Tel:  (02) 8003 3650Fax: (02) 9225 5050

Date first listed: 23/12/2013
Company Secretary: Andrew Cooke
Sector: Pharmaceuticals Biotechnology & Life Sciences Industry Group: XHJ
Activities: Pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis

News & Events

Expand this box to read and print

name changed from Innate Immunotherapeutics Limited

10/09/2018

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    03/08/2022Warwick Tong161,107$0.099$15,998
    10/02/2022Jane Bell222,342$0.167$37,042
    20/12/2021Jane Bell714,285$0.145$103,571
    02/09/2021Jane Bell593,914$0.199$117,892
    29/06/2017Michael Quinn-2,011,614$0.054$109,432

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Christopher BurnsManaging Director, CEO04/05/2018
    Tim LuscombeCFO25/09/2023
    Robert PeachNon Exec Director02/09/2015
    Jane BellNon Exec Director12/04/2021
    Warwick TongDirector04/05/2018

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Hamish GeorgeCFO01/10/202125/09/2023
    John LambertManaging Director, CEO24/06/201905/12/2022
    Jeff CarterCFO17/10/201301/10/2021
    Simon WilkinsonNon Exec Director22/11/200406/02/2020
    Andrew J CookeNon Exec Director13/10/201306/02/2020
    Christian BehrenbruchNon Exec Director04/05/201806/02/2020
    Michael QuinnNon Exec Chairman, Independent Director19/09/201304/05/2018
    Andrew SneddonIndependent Director19/09/201304/05/2018
    Elizabeth HopkinsNon Exec Director17/10/201304/05/2018
    Chris CollinsNon Exec Director20/02/200604/05/2018

    Date of first appointment, title may have changed.